Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Facilities Realignment (Tables)

Facilities Realignment (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

The following table presents a rollforward of the Company’s restructuring reserve from December 31, 2012 to March 31, 2013, of which approximately $1.2 million is included in other accrued expenses and $1.6 million is included in long-term liabilities as of March 31, 2013. The Company recognizes accretion expense in Other expense, net in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss).



	Sales Services			Marketing Services			Discontinued Operations			Total
Balance as of December 31, 2012	$	2,027		$	637		$	615		$	3,279
Accretion	28			—			7			35
Adjustments	—			—			—			—
Payments	(373		)	(51		)	(67		)	(491		)
Balance as of March 31, 2013	$	1,682		$	586		$	555		$	2,823

- Definition

Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.

+ References + Details